2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide

C73H119ClF3N13O15 — CID 171917853

IUPAC2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)CC(C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)C(C)(C)NC(=O)[C@H](COCC(=O)NC(C)(C)C)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](COCCC(C)C)N(C)C(=O)CN(C)C(=O)CN(C)C1=O
InChIInChI=1S/C73H119ClF3N13O15/c1-22-47(8)62-69(102)84(16)39-60(94)82(14)40-61(95)86(18)56(42-104-33-30-44(2)3)66(99)83(15)38-57(91)78-51(29-27-48-26-28-49(50(74)36-48)73(75,76)77)65(98)88(20)55(41-105-43-58(92)80-71(9,10)11)64(97)81-72(12,13)70(103)89(21)53(35-46(6)7)67(100)87(19)54(68(101)90-31-24-23-25-32-90)37-59(93)85(17)52(34-45(4)5)63(96)79-62/h26,28,36,44-47,51-56,62H,22-25,27,29-35,37-43H2,1-21H3,(H,78,91)(H,79,96)(H,80,92)(H,81,97)/t47-,51-,52-,53-,54?,55-,56-,62-/m0/s1
InChIKeyROWWMJUMGXCEID-QAIJSOJVSA-N
MW1511.28 g/mol
LogP4.21
Rot. Bonds19

About 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide

2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide (PubChem CID 171917853) has the molecular formula C73H119ClF3N13O15 and a molecular weight of 1511.28 g/mol. Its IUPAC name is 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide.

Molecular Properties

Compound Name2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide
PubChem CID171917853
Molecular FormulaC73H119ClF3N13O15
Molecular Weight1511.28 g/mol
Exact Mass1509.86
IUPAC Name2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)CC(C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)C(C)(C)NC(=O)[C@H](COCC(=O)NC(C)(C)C)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](COCCC(C)C)N(C)C(=O)CN(C)C(=O)CN(C)C1=O
InChIInChI=1S/C73H119ClF3N13O15/c1-22-47(8)62-69(102)84(16)39-60(94)82(14)40-61(95)86(18)56(42-104-33-30-44(2)3)66(99)83(15)38-57(91)78-51(29-27-48-26-28-49(50(74)36-48)73(75,76)77)65(98)88(20)55(41-105-43-58(92)80-71(9,10)11)64(97)81-72(12,13)70(103)89(21)53(35-46(6)7)67(100)87(19)54(68(101)90-31-24-23-25-32-90)37-59(93)85(17)52(34-45(4)5)63(96)79-62/h26,28,36,44-47,51-56,62H,22-25,27,29-35,37-43H2,1-21H3,(H,78,91)(H,79,96)(H,80,92)(H,81,97)/t47-,51-,52-,53-,54?,55-,56-,62-/m0/s1
InChIKeyROWWMJUMGXCEID-QAIJSOJVSA-N
XLogP4.21
TPSA317.65 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds19
Heavy Atoms105
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001511.28
LogP ≤ 54.21
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide?
The IUPAC name of 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide (CID 171917853) is 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide.
What is the SMILES notation for 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide?
The canonical SMILES for 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide is CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)CC(C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)C(C)(C)NC(=O)[C@H](COCC(=O)NC(C)(C)C)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](COCCC(C)C)N(C)C(=O)CN(C)C(=O)CN(C)C1=O.
What is the InChIKey of 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide?
The InChIKey is ROWWMJUMGXCEID-QAIJSOJVSA-N. The full InChI is InChI=1S/C73H119ClF3N13O15/c1-22-47(8)62-69(102)84(16)39-60(94)82(14)40-61(95)86(18)56(42-104-33-30-44(2)3)66(99)83(15)38-57(91)78-51(29-27-48-26-28-49(50(74)36-48)73(75,76)77)65(98)88(20)55(41-105-43-58(92)80-71(9,10)11)64(97)81-72(12,13)70(103)89(21)53(35-46(6)7)67(100)87(19)54(68(101)90-31-24-23-25-32-90)37-59(93)85(17)52(34-45(4)5)63(96)79-62/h26,28,36,44-47,51-56,62H,22-25,27,29-35,37-43H2,1-21H3,(H,78,91)(H,79,96)(H,80,92)(H,81,97)/t47-,51-,52-,53-,54?,55-,56-,62-/m0/s1.
What are the key properties of 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide?
2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide has a molecular weight of 1511.28 g/mol, XLogP of 4.21, 19 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(3S,9S,12S,18S,27S,30S)-27-[(2S)-butan-2-yl]-12-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-1,4,6,6,10,16,19,22,25,31-decamethyl-18-(3-methylbutoxymethyl)-3,30-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32-undecaoxo-34-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotetratriacont-9-yl]methoxy]-N-tert-butylacetamide is sourced from PubChem (CID 171917853), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).